Edding Genor Group Holdings Limited (HKG:6998)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.760
+0.150 (5.75%)
Mar 10, 2026, 4:08 PM HKT
43.75%
Market Cap 5.22B
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 2.00B
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 338,000
Average Volume 1,192,949
Open 2.610
Previous Close 2.610
Day's Range 2.610 - 2.800
52-Week Range 1.710 - 5.600
Beta 0.95
RSI 45.35
Earnings Date Mar 27, 2026

About HKG:6998

Edding Genor Group Holdings Limited, together with its subsidiaries, engages in the research, development, manufacturing, and distribution of biopharmaceutical products in China, the United States, and internationally. The company offers GB491, a differentiated CDK4/6 inhibitor for advanced or metastatic breast cancer; GB261, a novel CD3/CD20 bispecific antibody which is in clinical development for autoimmune diseases; and GB263T and GB268, tri-specific antibody candidates which are in preclinical and early clinical stages. It also provides Van... [Read more]

Sector Healthcare
Founded 2001
Employees 17
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6998
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.